Lymphoplasmacytic lymphoma primary prevention
|
Lymphoplasmacytic lymphoma Microchapters |
|
Differentiating Lymphoplasmacytic Lymphoma from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Lymphoplasmacytic lymphoma primary prevention On the Web |
|
American Roentgen Ray Society Images of Lymphoplasmacytic lymphoma primary prevention |
|
Risk calculators and risk factors for Lymphoplasmacytic lymphoma primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
There are no established measures for the primary prevention of [disease name].
OR
There are no available vaccines against [disease name].
OR
Effective measures for the primary prevention of [disease name] include [measure1], [measure2], and [measure3].
OR
[Vaccine name] vaccine is recommended for [patient population] to prevent [disease name]. Other primary prevention strategies include [strategy 1], [strategy 2], and [strategy 3].
Primary Prevention
Primary prevention of Waldenström macroglobulinemia depends on the type of risk factor causing the disease.[1]
Modifiable risk factors
Non-modifiable risk factors
- Age > 50
- Male gender
- Race - White
- Hereditary- Monoclonal gammopathy of undetermined significance
References
- ↑ Waldenström's macroglobulinemia. American Cancer Society. (2015)http://www.cancer.org/cancer/waldenstrommacroglobulinemia/detailedguide/waldenstrom-macroglobulinemia-prevention Accessed on November 11, 2015